INDU.A

335.6

+0.66%↑

INDU.C

335.9

+0.72%↑

AZA

313.3

+1.75%↑

ORES

119.66

-0.13%↓

INDU.A

335.6

+0.66%↑

INDU.C

335.9

+0.72%↑

AZA

313.3

+1.75%↑

ORES

119.66

-0.13%↓

INDU.A

335.6

+0.66%↑

INDU.C

335.9

+0.72%↑

AZA

313.3

+1.75%↑

ORES

119.66

-0.13%↓

INDU.A

335.6

+0.66%↑

INDU.C

335.9

+0.72%↑

AZA

313.3

+1.75%↑

ORES

119.66

-0.13%↓

INDU.A

335.6

+0.66%↑

INDU.C

335.9

+0.72%↑

AZA

313.3

+1.75%↑

ORES

119.66

-0.13%↓

Search

Bure Equity AB

Open

318.8 1.46

Overview

Share price change

24h

Current

Min

310.2

Max

319

Key metrics

By Trading Economics

Income

-1.3B

-1.3B

Sales

5M

15M

P/E

Sector Avg

3.925

20.525

EPS

-17.28

Dividend yield

0.91

Profit margin

-8,573.333

Employees

10

EBITDA

-3.6B

-1.3B

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.91%

4.36%

Next Earnings

15 May 2025

Market Stats

By TradingEconomics

Market Cap

-7.5B

22B

Previous open

317.34

Previous close

318.8

Bure Equity AB Chart

Past performance is not a reliable indicator of future results.

Related News

27 Apr 2025, 23:55 UTC

Market Talk

Oil Edges Higher Amid Hopes for Easing U.S.-China Trade Tensions -- Market Talk

27 Apr 2025, 23:47 UTC

Market Talk

Gold Falls Amid Dollar Strength, Signs of Easing U.S.-China Trade Tensions -- Market Talk

27 Apr 2025, 23:42 UTC

Market Talk

Nikkei May Rise as Fears About U.S.-China Tensions Ebb -- Market Talk

27 Apr 2025, 23:12 UTC

Earnings

Sinopharm Group 1Q Rev CNY141.66B Vs. CNY147.27B >1099.HK

27 Apr 2025, 23:12 UTC

Earnings

Sinopharm Group 1Q Net CNY1.46B Vs. Net CNY1.42B >1099.HK

27 Apr 2025, 20:41 UTC

Earnings

Pharmaron Beijing 1Q Net CNY305.58M Vs. Net CNY230.56M >300759.SZ

27 Apr 2025, 20:41 UTC

Earnings

Pharmaron Beijing: Higher Contributions From Laboratory Services Among Factors Supporting Results> 300759.SZ

27 Apr 2025, 20:41 UTC

Earnings

Pharmaron Beijing 1Q Rev CNY3.10B Vs. CNY2.67B >300759.SZ

27 Apr 2025, 18:41 UTC

Top News

Bessent Doesn't Know If Trump and Xi Have Talked on Trade -- Barrons.com

27 Apr 2025, 11:00 UTC

Top News

Wall Street's New Tariff Safe Haven: High-Tax Biotech Stocks -- Heard on the Street -- WSJ

27 Apr 2025, 05:41 UTC

Earnings

China Everbright Bank 1Q Net CNY12.46B Vs. Net CNY12.43B >601818.SH

27 Apr 2025, 05:41 UTC

Earnings

China Everbright Bank: Lower Net Interest Income Weighed on Operating Income>601818.SH

27 Apr 2025, 05:41 UTC

Earnings

China Everbright Bank 1Q Operating Income CNY33.10B Vs. CNY34.49B>601818.SH

27 Apr 2025, 05:41 UTC

Earnings

China Everbright Bank 1Q Impairment Loss on Credit Assets Was CNY8.49B; Down 15.6% on Year>601818.SH

27 Apr 2025, 05:41 UTC

Earnings

China Everbright Bank 1Q Operating Expenses Was CNY9.15B; Down 3.2%>601818.SH

27 Apr 2025, 05:41 UTC

Earnings

China Everbright Bank 1Q Net Interst Income Was CNY22.54B; Down 6.8% on Year>601818.SH

27 Apr 2025, 05:34 UTC

Earnings

Chongqing Rural Commercial Bank: 1Q Results Supported by Higher Net Interest Income>3618.HK

27 Apr 2025, 05:34 UTC

Earnings

Chongqing Rural Commercial Bank 1Q Operating Income CNY7.22B Vs. CNY7.13B>3618.HK

27 Apr 2025, 05:34 UTC

Earnings

Chongqing Rural Commercial Bank 1Q Net CNY3.75B Vs. Net CNY3.52B >3618.HK

27 Apr 2025, 05:29 UTC

Earnings

China Shenhua Energy: Results Weighed by Fall in Selling Prices of Coal >1088.HK

27 Apr 2025, 05:29 UTC

Earnings

China Shenhua Energy 1Q Net CNY13.37B Vs. Net CNY17.76B >1088.HK

27 Apr 2025, 05:29 UTC

Earnings

China Shenhua Energy 1Q Rev CNY69.59B Vs. CNY87.65B >1088.HK

27 Apr 2025, 05:29 UTC

Earnings

China Shenhua Energy: Lower Revenue From Electricity Sales Also Hurt Results >1088.HK

27 Apr 2025, 05:21 UTC

Earnings

CMOC Group 1Q Net CNY3.95B Vs. Net CNY2.07B >3993.HK

27 Apr 2025, 05:21 UTC

Earnings

CMOC Group: Cost Cuts Also Among Factors that Boosted 1Q Net >3993.HK

27 Apr 2025, 05:21 UTC

Earnings

CMOC Group 1Q Rev CNY46.01B Vs. CNY46.12B >3993.HK

27 Apr 2025, 05:21 UTC

Earnings

CMOC Group: Increase in Prices of Copper, Cobalt Supported Results>3993.HK

27 Apr 2025, 03:00 UTC

Top News

Chinese Manufacturers Are Scouring the World for New Buyers -- WSJ

27 Apr 2025, 00:30 UTC

Top News

Meta's 'Digital Companions' Will Talk Sex With Users -- Even Children -- WSJ

27 Apr 2025, 00:30 UTC

Top News

Meta's 'Digital Companions' Will Talk Sex With Users -- Even Children -- WSJ -2-

Peer Comparison

Price change

Bure Equity AB Forecast

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Bure Equity AB

Bure Equity AB (publ) is a private equity and venture capital firm specializing in secondary direct, later stage, middle market, mature, buyouts, emerging growth, expansion capital, mid venture, late venture, PIPES, bridge, industry consolidation, recapitalizations, growth capital, special situation and turnarounds. The firm has agnostic approach and seeks to invest in listed and unlisted SME companies and assets in knowledge driven service companies. It primarily invests in education service companies, communication services, medtech, consumer staples, financials, industrials, healthcare, information technology, and professional services. The firm prefers to invest in Nordic and European developed markets. It invests between $5 million to $100 million. The firm seeks to be a principal shareholder with a controlling influence in the portfolio company. The firm takes majority stake. The firm has no established exit strategy but prefers to hold its investment for a period of three to five years. It invests through its own balance sheet. Bure Equity AB (publ) was founded on November 23, 1992 and is based in Stockholm, Sweden.